How many of us give a “full” dose of chemotherapy to an obese patient—even in the curative setting? Dose calculation in the obese is a confusing but important puzzle for the oncologist and is becoming ...

Promise of New Vascular-Disrupting Agents Balanced With Cardiac Toxicity: Is It Time for Oncologists to Get to Know Their Cardiologists? Drugs are to the medical oncologist what the scalpel is to the ...

The Food and Drug Administration granted breakthrough device designation to a startup building software to help physicians prescribe the right dose of medication to patients with heart failure. Boston ...